BioSpace News Archive

Performance of the Unyvero HPN Panel for pneumonia proves to be strongly concordant (98.2%) compared to bacterial lower respiratory tract culture Collaboration with Karolinska Institutet highlights critical need for rapid diagnostic tests, as one in four COVID-19 patients in the ICU had a bacterial co-infection Providing results in hours instead of days provides clinicians with early organism differential, including resistance marker information, allowing earlier treatment decisions and s

Live Video Moderated Discussion with CEO, Jed Latkin, to be Held on Tuesday, June 16 th , at 2:00 PM ET, Immediately Followed by an Interactive Q&A Session

— Restructured HealthCare Royalty Partners elobixibat royalty monetization agreement nets additional $15M in non-dilutive capital — — Initial draw down of $10M on debt facility of up to $80M with Hercules Capital —

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it is expected to join the Russell 2000 ® Index at the conclusion of the annual Russell US Indexes reconstitution after the close of equity markets on June 26, 2020 .

Regence and Tabula Rasa HealthCare® announced that the companies have partnered on a virtual clinical trial to assess the risk of adverse drug events associated with drugs repurposed for the treatment of COVID-19.

CNS Pharmaceuticals, Inc., a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, announced highlights from its 2020 Annual Meeting of Shareholders.

Johnson & Johnson Consumer Health* will unveil a diverse set of studies covering areas such as skin microbiome and cleansing, pollution-induced skin damage, sun protection, skin hydration and others at the American Academy of Dermatology Virtual Meeting Experience 2020, which will launch June 12-14, 2020.

Novel application will enable Leading BioSciences to remotely monitor phase 2 study data in patients with COVID-19 pneumonia

SwiftScale Biologics announced it has successfully manufactured a COVID-19 neutralizing antibody candidate at clinical scale.

Menarini Silicon Biosystems, the pioneer of liquid biopsy and single cell technologies, announced that results from a new study presented at the virtual 2020 meeting of the American Society of Clinical Oncology suggest that circulating tumor cell counts may be useful in determining long-term prognosis and guiding treatment selection in patients with metastatic castrate sensitive prostate cancer.